The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

An Anhydrous Pharmaceutical Composition For Maintenance Treatment Of Psoriasis - EP4041186

The patent EP4041186 was granted to LEO Pharma on May 22, 2024. The application was originally filed on Oct 7, 2020 under application number EP20789063A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP4041186

LEO PHARMA
Application Number
EP20789063A
Filing Date
Oct 7, 2020
Status
Granted And Under Opposition
Apr 19, 2024
Publication Date
May 22, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

HGFFeb 24, 2025HGFADMISSIBLE
GENERICS UKFeb 21, 2025ELKINGTON AND FIFEADMISSIBLE
DR SCHONFeb 17, 2025DR SCHONADMISSIBLE

Patent Citations (4) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO2008141078
DESCRIPTIONWO2011154004
INTERNATIONAL-SEARCH-REPORTWO2011154004
OPPOSITIONWO2011154004

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents